3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
11
Osteoporosis
5
Prostatic Neoplasms
4
Neoplasms
4
Multiple Myeloma
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Regional Osteoporosis as a Result of Chemotherapy
1
Recurrence
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lymphedema
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Depression
1
Cicatrix
1
Cardiovascular Diseases
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
62
Dexamethasone
60
Melphalan
54
Peripheral Blood Stem Cell Transplantation
49
Bortezomib
40
Busulfan
39
fludarabine phosphate
34
Filgrastim
32
Lenalidomide
30
Thalidomide
27
Tacrolimus
25
Antilymphocyte Serum
23
Radiotherapy
22
Mycophenolic Acid
17
Methotrexate
17
Prednisone
15
Etoposide
15
sargramostim
14
Cyclosporine
14
fludarabine
12
Methylprednisolone
11
Granulocyte Colony-Stimulating Factor
11
Calcium Dobesilate
11
Whole-Body Irradiation
10
Doxorubicin
9
Carmustine
9
pomalidomide
8
Vincristine
8
Interferon-alpha
8
Cord Blood Stem Cell Transplantation
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasms, Plasma Cell
×
Absorptiometry, Photon
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts